Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Bases de dados
País/Região como assunto
Ano de publicação
Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
PLoS Negl Trop Dis ; 18(4): e0012134, 2024 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-38669211

RESUMO

BACKGROUND: Currently available treatment options are mostly effective in achieving long-term cure in visceral leishmaniasis (VL) patients. However, there have been reports of recurrence of this illness in both immunosuppressed and immunocompetent patients. CASE PRESENTATION: We report the first case of recurrent VL relapse in a 19-year-old immunocompetent female with functional hypopituitarism (hypogonadotropic hypogonadism with central hypothyroidism) from Bangladesh, who has been treated three times previously with optimal dosage and duration- liposomal amphotericin B (LAmB) alone and in combination with miltefosine. We treated the patient successfully with a modified treatment regimen of 10 mg/kg body weight LAmB for two consecutive days along with oral miltefosine for seven days as loading dose. For secondary prophylaxis, the patient received 3 mg/kg body weight LAmB along with oral miltefosine for seven days monthly for five doses followed by hormonal replacement. The patient remained relapse free after 12 months of her treatment completion. CONCLUSION: In the absence of protective vaccines against Leishmania species and standard treatment regimen, this modified treatment regimen could help the management of recurrent relapse cases.


Assuntos
Anfotericina B , Antiprotozoários , Hipopituitarismo , Leishmaniose Visceral , Fosforilcolina , Recidiva , Feminino , Humanos , Adulto Jovem , Anfotericina B/uso terapêutico , Anfotericina B/administração & dosagem , Antiprotozoários/uso terapêutico , Antiprotozoários/administração & dosagem , Bangladesh , Hipopituitarismo/tratamento farmacológico , Leishmaniose Visceral/tratamento farmacológico , Fosforilcolina/análogos & derivados , Fosforilcolina/uso terapêutico , Fosforilcolina/administração & dosagem , Resultado do Tratamento , Adulto
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA